{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:04:32Z","timestamp":1791428672934,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2685,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/mt.2009.17","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T15:04:54Z","timestamp":1235487894000},"page":"1053-1063","source":"Crossref","is-referenced-by-count":302,"title":["Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Ryan L","family":"Boudreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrie J","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly L","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2009.17_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol Cell"},{"key":"10.1038\/mt.2009.17_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1038\/mt.2009.17_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2009.17_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1038\/mt.2009.17_bib5","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Qiu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.17_bib6","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","article-title":"Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner","volume":"28","author":"Benn","year":"2008","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2009.17_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington's disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"key":"10.1038\/mt.2009.17_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2009.17_bib9","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2009.17_bib10","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2009.17_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2004.09.017","article-title":"Minocycline in phenotypic models of Huntington's disease","volume":"18","author":"Bantubungi","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.17_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.17_bib13","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.17_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.17_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci Res"},{"key":"10.1038\/mt.2009.17_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1038\/mt.2009.17_bib17","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2009.17_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1038\/mt.2009.17_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1038\/mt.2009.17_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2009.17_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","author":"van Bilsen","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.17_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nmeth.1261","article-title":"Linking SNPs to CAG repeat length in Huntington's disease patients","volume":"5","author":"Liu","year":"2008","journal-title":"Nat Methods"},{"key":"10.1038\/mt.2009.17_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.17_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1261\/rna.1062908","article-title":"Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs","volume":"14","author":"Boudreau","year":"2008","journal-title":"RNA"},{"key":"10.1038\/mt.2009.17_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2008.231","article-title":"Artificial MicroRNAs as siRNA Shuttles: improved safety as compared to shRNAs in vitro and in vivo","volume":"17","author":"Boudreau","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.17_bib26","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.17_bib27","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.17_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2004.07.011","article-title":"Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice","volume":"17","author":"Norflus","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.17_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.17_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.17_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.17_bib32","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang da","year":"2007","journal-title":"Genome Biol"},{"key":"10.1038\/mt.2009.17_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","article-title":"Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space","volume":"16","author":"Strehlow","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.17_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2202-9-38","article-title":"Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1038\/mt.2009.17_bib35","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbrc.2005.10.061","article-title":"siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro","volume":"338","author":"Omi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2009.17_bib36","doi-asserted-by":"crossref","first-page":"10458","DOI":"10.1073\/pnas.0401827101","article-title":"Genome-wide analysis of repressor element 1 silencing transcription factor\/neuron-restrictive silencing factor (REST\/NRSF) target genes","volume":"101","author":"Bruce","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.17_bib37","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1093\/nar\/gkl525","article-title":"Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication","volume":"34","author":"Johnson","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2009.17_bib38","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.17_bib39","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","article-title":"Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo","volume":"15","author":"Trushina","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.17_bib40","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1038\/mt.2009.17_bib41","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.17_bib42","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.17_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mt.2009.17_bib44","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1093\/nar\/gkm543","article-title":"Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC","volume":"35","author":"Castanotto","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2009.17_bib45","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.17_bib46","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.1523\/JNEUROSCI.3016-05.2005","article-title":"Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia","volume":"25","author":"Gonzalez-Alegre","year":"2005","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2009.17_bib47","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","article-title":"Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion","volume":"17","author":"White","year":"1997","journal-title":"Nat Genet"},{"issue":"22","key":"10.1038\/mt.2009.17_bib48","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","article-title":"The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin","volume":"10","author":"Auerbach","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1038\/mt.2009.17_bib49","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1089\/cmb.2005.12.882","article-title":"Stochastic models inspired by hybridization theory for short oligonucleotide arrays","volume":"12","author":"Wu","year":"2005","journal-title":"J Comput Biol"},{"key":"10.1038\/mt.2009.17_bib50","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616318111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616318111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T06:56:06Z","timestamp":1558162566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616318111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1525001616318111"],"URL":"https:\/\/doi.org\/10.1038\/mt.2009.17","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}